Citations for
1SLC2A10, SLC2A13, SLC2A5
The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia.
Lai B, Lai Y, Zhang Y, Zhou M, Sheng L, OuYang G.
Technol Cancer Res Treat 19:1533033819894308. doi: 10.1177/1533033819894308. 2020
2ATS, SLC2A10
Comprehensive in silico Study of GLUT10: Prediction of Possible Substrate Binding Sites and Interacting Molecules.
Hosen MJ, Hasan M, Chakraborty S, Abir RA, Zubaer A, Coucke P.
Curr Pharm Biotechnol 21(2):117-130. doi: 10.2174/1389201020666190613152030. 2020
3ATS, SLC2A10
Arterial Tortuosity Syndrome: An Ascorbate Compartmentalization Disorder?
Boel A, Veszelyi K, Németh CE, Beyens A, Willaert A, Coucke P, Callewaert B, Margittai É.
Antioxid Redox Signal ntioxid Redox Signal. 2019 Nov 14. doi: 10.1089/ars.2019.7843. [Epub ahead of print] 2019
4SLC2A10
GLUT10 maintains the integrity of major arteries through regulation of redox homeostasis and mitochondrial function.
Syu YW, Lai HW, Jiang CL, Tsai HY, Lin CC, Lee YC.
Hum Mol Genet 27(2):307-321. doi: 10.1093/hmg/ddx401. 2018
5SLC2A10
Localization of Glucose Transporter 10 to Hair Cells' Cuticular Plate in the Mouse Inner Ear.
Chen B, Wang Y, Geng M, Lin X, Tang W.
Biomed Res Int 2018:7817453. doi: 10.1155/2018/7817453. eCollection 2018. 2018
6ATS, SLC2A10
Arterial tortuosity syndrome: 40 new families and literature review.
Beyens A, Albuisson J, Boel A, Al-Essa M, Al-Manea W, Bonnet D, Bostan O, Boute O, Busa T, Canham N, Cil E, Coucke PJ, Cousin MA, Dasouki M, De Backer J, De Paepe A, De Schepper S, De Silva D, Devriendt K, De Wandele I, Deyle DR, Dietz H, Dupuis-Girod S, Fontenot E, Fischer-Zirnsak B, Gezdirici A, Ghoumid J, Giuliano F, Diéz NB, Haider MZ, Hardin JS, Jeunemaitre X, Klee EW, Kornak U, Landecho MF, Legrand A, Loeys B, Lyonnet S, Michael H, Moceri P, Mohammed S, Muińo-Mosquera L, Nampoothiri S, Pichler K, Prescott K, Rajeb A, Ramos-Arroyo M, Rossi M, Salih M, Seidahmed MZ, Schaefer E, Steichen-Gersdorf E, Temel S, Uysal F, Vanhomwegen M, Van Laer L, Van Maldergem L, Warner D, Willaert A, Collins TR, Taylor A, Davis EC, Zarate Y, Callewaert B.
Genet Med 20(10):1236-1245. doi: 10.1038/gim.2017.253. Epub 2018 Jan 11. Erratum in: Genet Med. 2018 Sep 10;:. 2018
7SLC2A10
GLUT10-Lacking in Arterial Tortuosity Syndrome-Is Localized to the Endoplasmic Reticulum of Human Fibroblasts.
Gamberucci A, Marcolongo P, Németh CE, Zoppi N, Szarka A, Chiarelli N, Hegedűs T, Ritelli M, Carini G, Willaert A, Callewaert BL, Coucke PJ, Benedetti A, Margittai É, Fulceri R, Bánhegyi G, Colombi M.
Int J Mol Sci 18(8). pii: E1820. doi: 10.3390/ijms18081820. 2017
8SLC2A10
Glucose transporter type 10-lacking in arterial tortuosity syndrome-facilitates dehydroascorbic acid transport.
Németh CE, Marcolongo P, Gamberucci A, Fulceri R, Benedetti A, Zoppi N, Ritelli M, Chiarelli N, Colombi M, Willaert A, Callewaert BL, Coucke PJ, Gróf P, Nagy SK, Mészáros T, Bánhegyi G, Margittai É.
FEBS Lett 590(11):1630-40. doi: 10.1002/1873-3468.12204. Epub 2016 May 27. 2016
9ATS, SLC2A10
Arterial Tortuosity Syndrome: homozygosity for two novel and one recurrent SLC2A10 missense mutations in three families with severe cardiopulmonary complications in infancy and a literature review.
Ritelli M, Chiarelli N, Dordoni C, Reffo E, Venturini M, Quinzani S, Monica MD, Scarano G, Santoro G, Russo MG, Calzavara-Pinton P, Milanesi O, Colombi M.
BMC Med Genet 15:122. doi: 10.1186/s12881-014-0122-5. Review. 2014
10SLC2A1, SLC2A10, SLC2A12, SLC2A9
Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells.
Pyla R, Poulose N, Jun JY, Segar L.
Am J Physiol Cell Physiol 304(6):C574-89. doi: 10.1152/ajpcell.00275.2012. Epub 2013 Jan 9. 2013
11SLC2A10
GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGFβ signaling.
Willaert A, Khatri S, Callewaert BL, Coucke PJ, Crosby SD, Lee JG, Davis EC, Shiva S, Tsang M, De Paepe A, Urban Z.
Hum Mol Genet 21(6):1248-59. doi: 10.1093/hmg/ddr555. Epub 2011 Nov 24. 2012
12ATS, SLC2A10
Glucose transporter 10 and arterial tortuosity syndrome: the vitamin C connection.
Segade F.
FEBS Lett 584(14):2990-4. Epub 2010 Jun 12. Review. 2010
13ATS, SLC2A10
Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome.
Lee YC, Huang HY, Chang CJ, Cheng CH, Chen YT.
Hum Mol Genet 19(19):3721-33. Epub 2010 Jul 16. 2010
14ATS, SLC2A10
Mutations in the SLC2A10 gene cause arterial abnormalities in mice.
Cheng CH, Kikuchi T, Chen YH, Sabbagha NG, Lee YC, Pan HJ, Chang C, Chen YT.
Cardiovasc Res 81(2):381-8. Epub 2008 Nov 21. 2009
15ATS, SLC2A10
A novel non-sense mutation in the SLC2A10 gene of an arterial tortuosity syndrome patient of Kurdish origin.
Zaidi SH, Meyer S, Peltekova VD, Lindinger A, Teebi AS, Faiyaz-Ul-Haque M.
Eur J Pediatr 168(7):867-70. Epub 2008 Sep 26. 2009
16ATS, SLC2A10
A novel missense and a recurrent mutation in SLC2A10 gene of patients affected with arterial tortuosity syndrome.
Faiyaz-Ul-Haque M, Zaidi SH, Al-Sanna N, Alswaid A, Momenah T, Kaya N, Al-Dayel F, Bouhoaigah I, Saliem M, Tsui LC, Teebi AS.
Atherosclerosis 203(2):466-71. Epub 2008 Aug 5. 2009
17SLC2A10, ATS
Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families.
Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B, Ramos-Arroyo MA, Doco-Fenzy M, Hennekam RC, Pyeritz RE, Krogmann ON, Gillessen-kaesbach G, Wakeling EL, Nik-zainal S, Francannet C, Mauran P, Booth C, Barrow M, Dekens R, Loeys BL, Coucke PJ, De Paepe AM.
Hum Mutat 29(1):150-8. 2008
18CDH22, HNF4A, PREX1, PTPN1, SLC2A10
Bento JL, Palmer ND, Zhong M, Roh B, Lewis JP, Wing MR, Pandya H, Freedman BI, Langefeld CD, Rich SS, Bowden DW, Mychaleckyj JC.
Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.
Genomics 92(4):226-34. Epub 2008 Aug 9. 2008
19SLC2A10, ATS
Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity syndrome.
Drera B, Guala A, Zoppi N, Gardella R, Franceschini P, Barlati S, Colombi M.
Am J Med Genet A 143(2):216-8. No abstract available. 2007
20SLC2A10, ATS
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.
Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A.
Nat Genet 38(4):452-7. Epub 2006 Mar 19. 2006
21ATS, SLC2A10
A GLUT of sugar leads to a tortuous future.
Kang M.
Clin Genet 70(2):111-3. No abstract available. 2006
22SLC2A10
Functional characterization of the promoter of the human glucose transporter 10 gene.
Segade F, Allred DC, Bowden DW.
Biochim Biophys Acta 1730(2):147-58. 2005
23SLC2A10, SLC2A12
Expression of Class III facilitative glucose transporter genes (GLUT-10 and GLUT-12) in mouse and human adipose tissues.
Wood IS, Hunter L, Trayhurn P.
Biochem Biophys Res Commun 308(1):43-9. 2003
24SLC2A10
Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility.
McVie-Wylie AJ, Lamson DR, Chen YT.
Genomics 72(1):113-7. 2001